Phase 2WithdrawnINTERVENTIONAL
Effect of Abaloparatide on Lumbar Disc Degeneration
ClinicalTrials.gov · NCT03708926 · Registry updated: 2021-04-12
- Condition / research focus
- Degeneration Disc Intervertebral
- Sponsor
- Johns Hopkins University
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2021-03. Completion: 2024-02 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Abaloparatide (drug) — also listed as: Tymlos, PTHrP
- Placebo (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Johns Hopkins University
Baltimore, Maryland, United States
Site recruitment: Not reported